At a dinner with reporters in San Francisco, OpenAI CEO Sam Altman spilled details on the company's ambitions beyond ChatGPT.

Over dinner, OpenAI CEO’s addressed criticism of GPT-5’s rollout, the AI bubble, brain-computer interfaces, buying Google ...

OpenAI's CEO is reportedly raising funds for a brain implant startup that would directly compete with Elon Musk's Neuralink.

The company, which has been referred to as Merge Labs, is looking at an approach involving gene therapy that would modify ...

Microsoft (MSFT)-backed OpenAI's latest venture, Merge Labs, is looking to develop a novel gene therapy approach targeting brain cells. Read more here.

After Musk said that 'Apple is behaving in a manner that makes it impossible for any AI company besides OpenAI to reach #1 in ...

Sam Altman plans to support a brain computer interface startup to rival Neuralink, as OpenAI expands its AI and technology ...

OpenAI CEO Sam Altman confirmed interest in acquiring Google Chrome, as the US government mandates its sale. This follows a ...

OpenAI's Sam Altman spoke frankly during an intimate dinner with reporters about the rocky debut of GPT-5 and the company’s ...

Investing.com -- OpenAI CEO Sam Altman revealed ambitious plans for the company’s future during a dinner with Verge reporters ...

OpenAI CEO Sam Altman is still talking like the future belongs to him, a week after the rollout of the company's latest model ...

OpenAI CEO Sam Altman is reportedly working to launch a new brain-to-computer interface company, Merge Labs, with early ...